CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in RLMD — Relmada Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in RLMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,956,401
+$1,586,958 QoQ
Shares Held
282,717
+432.6% QoQ
Ownership
0.265%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 126 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. RLMD ranks #184 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in RLMD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,956,401 | 282,717 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $369,443 | 53,081 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $256,381 | 53,081 | Shares | Sole | 2026-02-13 | |
| 2024-09-30 | $40,516 | 12,505 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $37,515 | 12,505 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $58,148 | 12,505 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $51,770 | 12,505 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $37,515 | 12,505 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $30,762 | 12,505 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $167,047 | 73,915 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $214,320 | 61,410 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,610,465 | 70,515 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,376,888 | 72,506 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,808,222 | 66,996 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,022,298 | 45,375 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,081,345 | 41,257 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,174,335 | 99,167 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,329,528 | 94,562 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,976,993 | 92,828 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,364,582 | 89,436 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,030,006 | 90,056 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $1,819,018 | 53,328 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||